Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024
Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024
Digital Solutions will Spark Integrated Development Approaches and Successful Adjunctive Therapies for Disease Modification
27-Aug-2019
North America
Description
As one lives longer, one needs to increasingly battle age-related disorders. Neurodegenerative disorders are the most worrisome, because they impact millions of people around the world and lack any curative therapy. While companies continue their search, they are also battling declining revenues from marketed products used to manage symptoms. Heavy genericization, followed by price erosion, reliance on patient-reported data for diagnosis and measuring outcomes, and elusive R&D success, has put unprecedented pressure on pharma companies and prompted several to shed their assets mid-way.
This research service, in addition to quantifying the market, provides details of future products and the expected revenue generation from them. While the therapy market is marred by high rates of pipeline attrition, there are several parallel areas of growth. For instance, the study covers regenerative medicine, which has grown by leaps and bounds and offers the promise of curative therapies. The study also dives deep into different technological advancements, geographical trends, and potential partnership opportunities for Alzheimer’s and Parkinson’s diseases. The study covers opportunities in prevention facilitated by digital solutions integration, in conjunction with an understanding of disease diagnosis and progression, expedited drug development, and, most importantly, delivery of the required outcome to the patient.
The study captures the competitive landscape and the different strategies employed by companies to stay ahead of the curve, and identifies the game-changing companies leading innovation from the front. Acknowledging the high cost of failure, the study investigates the need and growing acceptance of open innovation to curate data, ask better questions, extract meaningful insights, and create more accurate and predictable solutions. In addition to collaboration with peers, companies will seek partnership with digital partners. Given the growing availability of data, technologies and tools, and research expertise there are several companies seeking clinically validated solutions, which have been profiled in the study. The study lays down strategic imperatives for companies to recalibrate their business models based on collaboration and be future ready.
Information is also provided on some of the leading M&A activities impacting the market, as well as unconventional collaboration agreements laying the foundation for propelling innovations toward licensure and delivery. Furthermore, present and future market trends such as regulatory support, focus on wellness, and value chain convergence, which would shape the market, are discussed.
Key Issues Addressed
- What is the total market size and how is the growth projected for global neurodegenerative therapeutics? Which are the largest growth segments to be pursued?
- How are the various regions around the globe positioned to monetize market opportunities? What are the key regional barriers to entry?
- What are the new risk mitigation strategies and alternative big bets to circumvent R&D challenges? Which are the lucrative partnership models for the long term?
- What are the market-defining macro trends mandating the need to deploy new digital therapeutic solutions to enable centric care in a variety of settings?
- What are the implications of emerging technologies and digital transformation on the overall market?
- Which are the key game-changing companies in the segment and how are they riding the growth curve?
Author: Khushbu Jain
Table of Contents
Purpose of the Study
5-step Process to Transformational Growth
Key Findings
Key Questions this Study will Answer
Market Engineering Measurements
Big Market Themes
Strategic Imperatives for Success and Growth
Scope and Segmentation
Scale of the Challenge—Alzheimer’s
Scale of the Challenge—Parkinson’s
Market Drivers and Restraints
R&D Productivity in Alzheimer’s Disease
R&D Productivity in Parkinson’s Disease
Funding Set to Catapult Pharma and Digital Solutions
Impact of Regulatory and Pricing Policies
Global Innovation Outlook
Treatment Workflow
Market Engineering Measurements
Methodology
Forecast Assumptions
Snapshot of Disease Diagnosis and Management
Market Engineering Measurements
Revenue Forecast
Addressable Opportunity—Pharmacological Therapies
Revenue Forecast Discussion
Competitive Landscape
Clinical Pipeline Overview
High-potential Pipeline Products
Snapshot of Disease Diagnosis and Management
Market Engineering Measurements
Revenue Forecast Discussion
Addressable Opportunity—Pharmacological Therapies
Revenue Forecast Discussion
Competitive Landscape
Clinical Pipeline Overview
High-potential Pipeline Products
Competitive Environment
Collaboration Assessment
Collaboration Assessment (continued)
Collaboration Assessment (continued)
Vendor Ecosystem
Key Companies to Watch
Key Companies to Watch (continued)
Macro-to-Micro Visioning
Change on the Horizon—Applications for Digital Integration
Addressable Market Opportunity—Digital Solutions
Reimbursement Landscape for Digital Therapies
Case Study—Digitization of Drug Discovery: BenevolentAI
Case Study—Digitization of Screening for Clinical Trial
Case Study—Digitization of Clinical Trial: µMotif
Case Study—Digitization of Therapy
Case Study—Digitization of Therapy: Dthera Sciences
Case Study—Digitization-enabling Personalized Therapy
5 Major Growth Opportunities
Growth Opportunity 1—Digital Biomarkers
Definition and Applications of Digital Biomarkers
Overview of Relevant Digital Biomarkers
Growth Opportunity 2—Microbiome Therapeutics
Companies at the Forefront of Research
Growth Opportunity 3—Cell and Gene Therapy
Regenerative Medicine Clinical Trials Overview
Growth Opportunity 4—Drug Delivery
Collaborating to Bring Innovative Drug-Device Combination
Growth Opportunity 5—Drug Repurposing
Overview of Drug Repurposing Trials
Deficiencies in the Treatment Paradigm
Top 3 Predictions for the Market
Legal Disclaimer
Statistics on Alzheimer’s Disease
Statistics on Parkinson’s Disease
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Related Research
Popular Topics
Key Issues Addressed
- What is the total market size and how is the growth projected for global neurodegenerative therapeutics? Which are the largest growth segments to be pursued?
- How are the various regions around the globe positioned to monetize market opportunities? What are the key regional barriers to entry?
- What are the new risk mitigation strategies and alternative big bets to circumvent R&D challenges? Which are the lucrative partnership models for the long term?
- What are the market-defining macro trends mandating the need to deploy new digital therapeutic solutions to enable centric care in a variety of settings?
- What are the implications of emerging technologies and digital transformation on the overall market?
- Which are the key game-changing companies in the segment and how are they riding the growth curve?
Author: Khushbu Jain
No Index | No |
---|---|
Podcast | No |
Author | Khushbu Jain |
Industries | Healthcare |
WIP Number | MECB-01-00-00-00 |
Is Prebook | No |
GPS Codes | 9564-B1,9575-B1,9600-B1,9612-B1,9562-B1,9571-B1,9573-B1,99BC-B1,99C1-B1,99C6-B1,9568-B1,9611-B1,9627-B1 |